Evidence map›Paper›PMID 39565935›Full record

ArticleMedical physics2025

'Dirty dose'-based proton variable RBE models - performance assessment on in vitro data.

Fredrik Kalholm, Iuliana Toma-Dasu, Erik Traneus

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fredrik KalholmMedical Radiation Physics, Department of Physics, Stockholm University, Stockholm, Sweden.
Iuliana Toma-DasuMedical Radiation Physics, Department of Physics, Stockholm University, Stockholm, Sweden.
Erik TraneusRaysearch Laboratories AB, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn clinical proton radiotherapy, a constant relative biological effectiveness (RBE) of 1.1 is typically applied. Due to abundant evidence of variable RBE effects from in vitro data, multiple variable RBE models have been suggested, typically by describing the PURPOSE: This work introduces a new variable RBE model based on the dirty dose concept, where dose deposited in voxels with a corresponding LET exceeding a specific threshold is considered "dirty" in the sense that it has a biological effect above the one predicted by a constant RBE of 1.1. As only one LET level, corresponding to a specific energy for a given particle in a given medium, needs to be monitored, this offers several advantages, such as simplified calculations by removing the need for intricate end of range LET calculations and averaging procedures, as well as opening up for more efficient experimental assessment of the cell specific model parameters.

methodsPreviously published in vitro data were utilized, where surviving fraction (SF), dose and

resultsVariable RBE models based on dirty dose perform on par with conventional radiation quality metrics with a RMSE of 0.38 for a dirty dose-based model with a threshold of 7

conclusionThe results indicate that models based on dirty dose metrics perform equally well as conventional radiation quality metrics. Due to the simplified calculations involved and the potential for more efficient measurement techniques for data generation, dirty dose-based models might be the most conservative and practical approach for creating future proton variable RBE models.

Indexed as

Models, BiologicalProton TherapyRadiation DosageRelative Biological EffectivenessHumansLinear Energy TransferRadiotherapy Dosagedirty doseLETRBE

Identifiers

PMID39565935
PMCPMC11788267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.